老年急诊严重激越用药比较安全性:老年急诊科指南2.0系统综述
该系统综述纳入8项观察性研究和1项随机临床试验,比较老年急诊或院前严重激越患者使用抗精神病药或镇静药的安全性。观察性研究838例中16.8%发生不良事件,咪达唑仑不良事件风险显著高于氟哌啶醇(OR 5.25,95%CI 2.64-10.45),喹硫平风险较低(OR 0.27,95%CI 0.08-0.97)。
要点
- 老年严重激越用药不良事件常见,观察性研究中发生率为16.8%。
- 咪达唑仑不良事件风险显著高于氟哌啶醇,OR为5.25。
- 喹硫平不良事件频率低于氟哌啶醇,OR为0.27。
核心结论
- 老年严重激越患者使用抗精神病药或抗焦虑药时不良事件常见。
- 苯二氮䓬类药物尤其是咪达唑仑对老年严重激越患者构成过高风险。
研究设计与样本
- 系统综述,检索8个数据库截至2024年2月,纳入8项观察性研究和1项随机临床试验。
- 观察性研究共838例老年患者,涉及氟哌啶醇、氟哌利多、劳拉西泮、咪达唑仑、奥氮平、喹硫平、齐拉西酮。
主要发现
- 838例中141例(16.8%)发生任何不良事件。
- 咪达唑仑组不良事件发生率53%(36/68),为各组最高。
- 以氟哌啶醇为参照,咪达唑仑任何不良事件OR为5.25(95%CI 2.64-10.45)。
- 喹硫平任何不良事件OR为0.27(95%CI 0.08-0.97)。
关键数值与推荐
- 纳入研究考察第一代抗精神病药、第二代抗精神病药、苯二氮䓬类或氯胺酮。
- 提取不良事件包括呼吸事件(呼吸暂停、低氧血症、插管)及其他事件(心律失常、低血压、谵妄加重、心脏骤停、死亡)。
- 以氟哌啶醇为参照组计算OR。
临床怎么用
- 老年急诊严重激越需药物治疗时,应警惕苯二氮䓬类尤其是咪达唑仑的过高不良事件风险。
- 氟哌啶醇可作为比较参照,喹硫平观察到较低不良事件频率。
局限性
- 多数证据来自观察性研究,仅1项随机临床试验。
- 观察性研究样本量有限,部分药物组例数较少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Managing undifferentiated, severe agitation in older adults may require antipsychotic or sedative medications to prevent harm to self or others. Unfortunately, these medications are associated with serious adverse events in older adults, and little is known about their comparative safety. METHODS: We conducted a systematic review to identify comparative effectiveness studies on the safety of medications used in the treatment of severe agitation among older adults in the prehospital or emergency department (ED) setting. We searched eight databases including PubMed, EMBASE, SCOPUS, Cochrane library, CINAHL, Proquest Central, Ageline, and PsycInfo published in or before February 2024. Studies were included if they examined 1st generation antipsychotics, 2nd generation antipsychotics, benzodiazepines, or ketamine. Data were extracted on adverse respiratory events (apnea, hypoxemia, intubation) and other adverse events (arrhythmia, hypotension, worsening delirium, cardiac arrest, and mortality). We report the aggregate occurrence of any adverse events pooled by drug and report odds ratios (ORs) using haloperidol as the reference group. RESULTS: Among 8600 studies identified, eight observational studies and one randomized clinical trial met eligibility for further qualitative and quantitative analysis. The observational studies included 838 older adults receiving haloperidol (n = 117), droperidol (n = 129), lorazepam (n = 350), midazolam (n = 68), olanzapine (n = 101), quetiapine (n = 56), and ziprasidone (n = 17). Any adverse events were observed in 16.8% of the patients (141/838). Adverse events were most common among patients receiving midazolam (53%; 36/68). Relative to haloperidol, midazolam significantly increased the risk for any adverse events (OR 5.25 [95% CI: 2.64-10.45]). Quetiapine was the only drug observed to have a lower frequency of adverse events (OR 0.27 [95% CI: 0.08, 0.97]). CONCLUSIONS: Adverse drug events are common among older adults receiving antipsychotic or anxiolytic medications for severe agitation. Benzodiazepines, particularly midazolam, pose an excessive risk to older adults requiring pharmacologic treatment for severe agitation.
引用
- Casey MF, Elder NM, Fenn A, et al. Comparative Safety of Medications for Severe Agitation: A Geriatric Emergency Department Guidelines 2.0 Systematic Review. J Am Geriatr Soc. 2025. PMID: 40275439. doi:10.1111/jgs.19485
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。